HEADER HYDROLASE 21-MAY-07 2V13 TITLE CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 7 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: CHO KEYWDS GLYCOPROTEIN, INHIBITOR-COMPLEX, ASPARTYL PROTEASE, ZYMOGEN, KEYWDS 2 PROTEASE, HYDROLASE, POLYMORPHISM, ALTERNATIVE SPLICING, KEYWDS 3 HYDROLASE(ACID PROTEINASE), CLEAVAGE ON PAIR OF BASIC RESIDUES EXPDTA X-RAY DIFFRACTION AUTHOR J.RAHUEL,V.RASETTI,J.MAIBAUM,H.RUEGER,R.GOSCHKE,N.C.COHEN,S.STUTZ, AUTHOR 2 F.CUMIN,W.FUHRER,J.M.WOOD,M.G.GRUTTER REVDAT 5 03-APR-19 2V13 1 SOURCE REVDAT 4 12-JUL-17 2V13 1 REVDAT 3 28-JUN-17 2V13 1 REMARK REVDAT 2 24-FEB-09 2V13 1 VERSN REVDAT 1 08-JUL-08 2V13 0 JRNL AUTH J.RAHUEL,V.RASETTI,J.MAIBAUM,H.RUEGER,R.GOSCHKE,N.C.COHEN, JRNL AUTH 2 S.STUTZ,F.CUMIN,W.FUHRER,J.M.WOOD,M.G.GRUTTER JRNL TITL STRUCTURE-BASED DRUG DESIGN: THE DISCOVERY OF NOVEL JRNL TITL 2 NONPEPTIDE ORALLY ACTIVE INHIBITORS OF HUMAN RENIN JRNL REF CHEM.BIOL. V. 7 493 2000 JRNL REFN ISSN 1074-5521 JRNL PMID 10903938 JRNL DOI 10.1016/S1074-5521(00)00134-4 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.RAHUEL,J.P.PRIESTLE,M.G.GRUTTER REMARK 1 TITL THE CRYSTAL STRUCTURES OF RECOMBINANT GLYCOSYLATED HUMAN REMARK 1 TITL 2 RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG REMARK 1 TITL 3 INHIBITOR. REMARK 1 REF J.STRUCT.BIOL. V. 107 227 1991 REMARK 1 REFN ISSN 1047-8477 REMARK 1 PMID 1807356 REMARK 1 DOI 10.1016/1047-8477(91)90048-2 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 10398 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2500 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.022 REMARK 3 BOND ANGLES (DEGREES) : 3.730 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.60 REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2V13 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1290032550. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-93 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR571 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : DELFT REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MADNESS REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10676 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.580 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 3 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.80000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 49.20000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 49.20000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 23.90000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 49.20000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 49.20000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 71.70000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 49.20000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.20000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 23.90000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 49.20000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.20000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 71.70000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 47.80000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 1 REMARK 465 THR A 2 REMARK 465 LEU A 3 REMARK 465 GLY A 4 REMARK 465 SER A 166 REMARK 465 GLU A 167 REMARK 465 ASN A 168 REMARK 465 SER A 169 REMARK 465 GLN A 170 REMARK 465 SER A 171 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 50 CG CD CE NZ REMARK 470 ARG A 53 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 78 CG CD OE1 OE2 REMARK 470 ARG A 139 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 154 CG CD CE NZ REMARK 470 ASP A 165 CA C O CB CG OD1 OD2 REMARK 470 SER A 237 OG REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 LYS A 293 CG CD CE NZ REMARK 470 ARG A 330 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASN A 5 CA - C - N ANGL. DEV. = -20.4 DEGREES REMARK 500 THR A 7 N - CA - CB ANGL. DEV. = -12.8 DEGREES REMARK 500 ASN A 14 CA - C - N ANGL. DEV. = 15.0 DEGREES REMARK 500 MET A 16 CA - CB - CG ANGL. DEV. = -14.2 DEGREES REMARK 500 VAL A 36 CG1 - CB - CG2 ANGL. DEV. = -10.3 DEGREES REMARK 500 TRP A 45 CA - CB - CG ANGL. DEV. = 11.5 DEGREES REMARK 500 TRP A 45 CD1 - CG - CD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 TRP A 45 CE2 - CD2 - CG ANGL. DEV. = -5.2 DEGREES REMARK 500 TYR A 72 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 THR A 77 CA - CB - OG1 ANGL. DEV. = -13.1 DEGREES REMARK 500 ARG A 82 NE - CZ - NH2 ANGL. DEV. = -4.7 DEGREES REMARK 500 VAL A 111 CA - CB - CG2 ANGL. DEV. = -10.7 DEGREES REMARK 500 GLU A 113 N - CA - C ANGL. DEV. = -17.0 DEGREES REMARK 500 VAL A 140 CA - CB - CG1 ANGL. DEV. = -9.4 DEGREES REMARK 500 TYR A 162 CB - CG - CD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 TYR A 162 CB - CG - CD1 ANGL. DEV. = 4.2 DEGREES REMARK 500 TYR A 186 CB - CG - CD1 ANGL. DEV. = -3.6 DEGREES REMARK 500 ILE A 196 N - CA - C ANGL. DEV. = -17.5 DEGREES REMARK 500 TRP A 201 CD1 - CG - CD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 TRP A 201 CE2 - CD2 - CG ANGL. DEV. = -5.9 DEGREES REMARK 500 TRP A 201 CG - CD2 - CE3 ANGL. DEV. = 5.6 DEGREES REMARK 500 CYS A 217 CA - CB - SG ANGL. DEV. = -11.9 DEGREES REMARK 500 ALA A 229 O - C - N ANGL. DEV. = -9.6 DEGREES REMARK 500 LYS A 258 CA - CB - CG ANGL. DEV. = 16.1 DEGREES REMARK 500 ASP A 267 CB - CG - OD2 ANGL. DEV. = -8.2 DEGREES REMARK 500 ALA A 282 CB - CA - C ANGL. DEV. = -10.3 DEGREES REMARK 500 MET A 303 CA - CB - CG ANGL. DEV. = -18.2 DEGREES REMARK 500 MET A 303 CG - SD - CE ANGL. DEV. = -13.3 DEGREES REMARK 500 TRP A 313 CD1 - CG - CD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 TRP A 313 CE2 - CD2 - CG ANGL. DEV. = -5.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 9 148.51 -170.47 REMARK 500 ASP A 17 2.45 59.41 REMARK 500 GLN A 19 114.93 -164.52 REMARK 500 LYS A 50 0.26 -66.69 REMARK 500 ARG A 53 -45.76 -23.20 REMARK 500 SER A 67 -51.42 -26.72 REMARK 500 ASP A 68 54.44 -91.21 REMARK 500 TYR A 72 95.04 -65.88 REMARK 500 ARG A 82 77.62 -103.49 REMARK 500 SER A 84 -14.25 -49.33 REMARK 500 ASP A 95 -163.02 171.92 REMARK 500 THR A 112 -64.63 -150.31 REMARK 500 PHE A 119 -9.25 -59.69 REMARK 500 MET A 130 31.22 -145.10 REMARK 500 LYS A 154 -81.90 -65.56 REMARK 500 SER A 181 108.68 -167.69 REMARK 500 PRO A 183 32.98 -81.11 REMARK 500 ASN A 189 115.17 32.88 REMARK 500 LEU A 195 -158.02 -70.97 REMARK 500 ILE A 196 -74.82 -140.73 REMARK 500 SER A 212 35.31 -153.58 REMARK 500 ASP A 219 45.83 -99.65 REMARK 500 LEU A 252 -93.09 39.60 REMARK 500 CYS A 259 -29.54 -38.29 REMARK 500 SER A 289 126.91 172.81 REMARK 500 LYS A 293 -66.71 80.20 REMARK 500 ALA A 299 40.58 -73.38 REMARK 500 ALA A 339 -178.83 -31.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 15 0.09 SIDE CHAIN REMARK 500 TYR A 60 0.08 SIDE CHAIN REMARK 500 TYR A 255 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C40 A1341 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BBS RELATED DB: PDB REMARK 900 RENIN REMARK 900 RELATED ID: 1BIL RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: RENIN; CHAIN: A, B; ENGINEERED: YES; HETEROGEN: REMARK 900 BUTANEDIAMIDE INHIBITOR BILA 1908; OTHER_DETAILS: GLYCOSYLATED REMARK 900 RELATED ID: 1BIM RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: RENIN; CHAIN: A, B; ENGINEERED: YES; HETEROGEN: REMARK 900 BUTANEDIAMIDE INHIBITOR BILA 2151; OTHER_DETAILS: GLYCOSYLATED REMARK 900 RELATED ID: 1HRN RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH POLYHYDROXYMONOAMIDE INHIBITOR BILA 980 REMARK 900 RELATED ID: 1PR7 RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH COMPOUND IB REMARK 900 RELATED ID: 1PR8 RELATED DB: PDB REMARK 900 HUMAN RENIN COMPLEXED WITH A SUBSTITUTED PIPERIDINE REMARK 900 RELATED ID: 1RNE RELATED DB: PDB REMARK 900 RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) COMPLEX WITH CGP 38'560 REMARK 900 RELATED ID: 1UHQ RELATED DB: PDB REMARK 900 HUMAN RENIN COMPLEXED WITH A SUBSTITUTED PIPERIDINE REMARK 900 RELATED ID: 2BKS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN-PF00074777 COMPLEX REMARK 900 RELATED ID: 2BKT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN-PF00257567 COMPLEX REMARK 900 RELATED ID: 2G20 RELATED DB: PDB REMARK 900 KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THEC RING REMARK 900 RELATED ID: 2REN RELATED DB: PDB REMARK 900 RENIN REMARK 900 RELATED ID: 2V0Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 10 (ALISKIREN) REMARK 900 RELATED ID: 2V10 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 9 REMARK 900 RELATED ID: 2V11 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 6 REMARK 900 RELATED ID: 2V12 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 8 REMARK 900 RELATED ID: 2V16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 3 DBREF 2V13 A 1 340 UNP P00797 RENI_HUMAN 67 406 SEQRES 1 A 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 A 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 A 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 A 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 A 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 A 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 A 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 A 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 A 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 A 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 A 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 A 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 A 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 A 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 A 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 A 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 A 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 A 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 A 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 A 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 A 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 A 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 A 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 A 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 A 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 A 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 A 340 ALA ARG HET C40 A1341 33 HETNAM C40 N-[(2R,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)-5-HYDROXY-2,7- HETNAM 2 C40 DIMETHYL-8-OXOOCTYL]-2-(3-METHOXYPROPOXY)BENZAMIDE FORMUL 2 C40 C25 H43 N3 O5 HELIX 1 1 TYR A 55 TYR A 60 1 6 HELIX 2 2 ASP A 65 SER A 69 5 5 HELIX 3 3 PRO A 115 MET A 120 1 6 HELIX 4 4 PHE A 132 ALA A 136 5 5 HELIX 5 5 PRO A 142 GLN A 150 1 9 HELIX 6 6 SER A 235 GLY A 247 1 13 HELIX 7 7 LYS A 258 LEU A 265 5 8 HELIX 8 8 THR A 280 VAL A 285 1 6 HELIX 9 9 GLY A 316 ARG A 321 1 6 SHEET 1 AA 3 HIS A 74 TYR A 83 0 SHEET 2 AA 3 GLY A 86 VAL A 99 -1 O GLY A 86 N TYR A 83 SHEET 3 AA 3 GLN A 19 ILE A 26 -1 O GLY A 25 N THR A 98 SHEET 1 AB 7 HIS A 74 TYR A 83 0 SHEET 2 AB 7 GLY A 86 VAL A 99 -1 O GLY A 86 N TYR A 83 SHEET 3 AB 7 ILE A 102 GLU A 113 -1 O ILE A 102 N VAL A 99 SHEET 4 AB 7 VAL A 44 PRO A 47 1 O VAL A 44 N GLY A 109 SHEET 5 AB 7 GLY A 126 GLY A 129 -1 O VAL A 127 N TRP A 45 SHEET 6 AB 7 GLN A 31 ASP A 38 1 O VAL A 36 N VAL A 128 SHEET 7 AB 7 GLN A 19 ILE A 26 -1 O GLY A 22 N VAL A 35 SHEET 1 AC 4 SER A 213 LEU A 216 0 SHEET 2 AC 4 GLN A 202 VAL A 210 -1 O VAL A 208 N LEU A 215 SHEET 3 AC 4 CYS A 221 VAL A 225 -1 O CYS A 221 N MET A 205 SHEET 4 AC 4 TRP A 313 LEU A 315 1 O TRP A 313 N LEU A 224 SHEET 1 AD 4 SER A 213 LEU A 216 0 SHEET 2 AD 4 GLN A 202 VAL A 210 -1 O VAL A 208 N LEU A 215 SHEET 3 AD 4 ILE A 268 LEU A 272 -1 O SER A 269 N SER A 209 SHEET 4 AD 4 LYS A 275 LEU A 279 -1 O LYS A 275 N LEU A 272 SHEET 1 AE 2 ILE A 232 GLY A 234 0 SHEET 2 AE 2 ILE A 300 ALA A 302 1 O HIS A 301 N GLY A 234 SHEET 1 AF 2 VAL A 256 VAL A 257 0 SHEET 2 AF 2 CYS A 296 THR A 297 -1 O CYS A 296 N VAL A 257 SSBOND 1 CYS A 51 CYS A 58 1555 1555 2.02 SSBOND 2 CYS A 217 CYS A 221 1555 1555 2.01 SSBOND 3 CYS A 259 CYS A 296 1555 1555 2.01 CISPEP 1 THR A 28 PRO A 29 0 2.46 CISPEP 2 LEU A 117 PRO A 118 0 13.05 CISPEP 3 PRO A 307 PRO A 308 0 9.68 CISPEP 4 GLY A 310 PRO A 311 0 26.73 SITE 1 AC1 13 GLN A 19 TYR A 20 ASP A 38 GLY A 40 SITE 2 AC1 13 ARG A 82 TYR A 83 SER A 84 THR A 85 SITE 3 AC1 13 PRO A 118 ILE A 137 ASP A 226 THR A 227 SITE 4 AC1 13 GLY A 228 CRYST1 98.400 98.400 95.600 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010163 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010163 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010460 0.00000 MASTER 419 0 1 9 22 0 4 6 0 0 0 27 END